Xuesen Dong

Associate Professor

The University of British Columbia

Canada

Research Interests

Explore related searches

Professors in Canada Professors in Cancer Biology Cancer Biology professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Xuesen Dong is an Associate Professor at the University of British Columbia, Canada. His research primarily focuses on the molecular mechanisms underlying prostate cancer, including the role of androgen receptors, stemness in cancer cells, and the potential of novel inhibitors for cancer therapy. His recent articles delve into topics such as synthetic lethality in cancer treatments and RNA splicing as a tool for enhancing cancer diagnosis and therapy.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Collaborators (4)

xiaodong Lu

Northwestern University

UNITED STATES

View details

Jonathan Zhao

Associate Professor

Emory University

UNITED STATES

View details

Qi Cao

Associate Professor

Northwestern University

UNITED STATES

View details

Nada Lallous

The University of British Columbia

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Xuesen Dong

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Palmitoyl acyltransferase ZDHHC7 inhibits androgen receptor and suppresses prostate cancer

TRIM59 is suppressed by androgen receptor and acts to promote lineage plasticity and treatment-induced neuroendocrine differentiation in prostate cancer

The Implication of Topoisomerase II Inhibitors in Synthetic Lethality for Cancer Therapy

Discovery of Novel Lin28 Inhibitors to Suppress Cancer Cell Stemness

Lin28 Regulates Cancer Cell Stemness for Tumour Progression

Interferon signalling contributes to therapy‐resistant prostate cancer progression

Methylation-dependent and -independent roles of EZH2 synergize in CDCA8 activation in prostate cancer

Optimization of New Catalytic Topoisomerase II Inhibitors as an Anti-Cancer Therapy

miR‐30a inhibits androgen‐independent growth of prostate cancer via targeting MYBL2, FOXD1, and SOX4

Understanding aberrant RNA splicing to facilitate cancer diagnosis and therapy

Collaborators (4)

xiaodong Lu

Jonathan Zhao

Qi Cao

Nada Lallous

Make your next move.